U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

HealthDay Logo

Imaging System Lets Doctors 'See' Cancer During Surgery

Fluorescent dyes light up diseased tissue on video monitors, helping spare healthy cells
Printer-friendly version Printer-friendly version

HealthDay

By Robert Preidt

Tuesday, August 19, 2008

HealthDay news imageTUESDAY, Aug. 19 (HealthDay News) -- A new imaging system that highlights cancerous tissue makes it easier for surgeons to detect and remove tumors without harming surrounding healthy tissue, according to U.S. researchers.

The fluorescence-assisted resection and exploration (FLARE) system --which consists of a near-infrared (NIR) imaging system, a video monitor and a computer -- shows particular promise for improving surgery for breast, prostate and lung cancers. In advanced stages, the boundaries of these cancers can be difficult to define. FLARE may also help cancer surgeons avoid cutting important structures such as blood vessels and nerves.

Patients are injected with special dyes (NIR fluorphores) that target specific structures such as cancer cells. When exposed to NIR light, the dyes light up the cancer cells, which appear on a video monitor.

Details about the development and early clinical trials of the new system were to be presented Aug. 19 at the national meeting of the American Chemical Society, in Philadelphia.

"This technique is really the first time that cancer surgeons can see structures that are otherwise invisible, providing true image-guided surgery. If we're able to see cancer, we have a chance of curing it," project director Dr. John Frangioni, co-director of the Center for Imaging Technology and Molecular Diagnostics at Beth Israel Deaconess Medical Center in Boston, said in an ACS news release.

In preliminary trials, the researchers used FLARE to visualize organs and body fluids of mice and map the lymph nodes of pigs, all in real time. The first human clinical trials, which may begin this summer, will involve mapping the lymph nodes of breast cancer patients.

Currently, cancer surgeons have no clear way to determine in real-time whether they've removed all of a patient's cancerous tissue.


HealthDay

Copyright (c) 2008 ScoutNews, LLC. All rights reserved.

Related News:
More News on this Date

Related MedlinePlus Pages: